P&G Stock Surges to an 8-Month High: Earnings Beat Sends Investors Running to Safety

Short answer: Procter & Gamble stock (NYSE: PG) surged nearly 6% on Thursday, October 22, 2026, closing at $165.59 — its highest level since February — after the consumer goods giant beat Wall Street's fiscal first-quarter earnings and sales estimates, grew sales in all five of its business segments, and held its full-year guidance steady on a day when tech stocks were getting hammered.

What happened

Procter & Gamble reported fiscal Q1 2027 results before the opening bell on Thursday, and the numbers came in cleanly ahead of expectations. Core earnings per share were $2.00, up 1% from a year earlier and above the consensus estimate of $1.89. Net sales rose 4% year over year to $23.28 billion, beating analyst expectations of roughly $22.8 billion, while organic sales also grew 4% — driven by a 2.4% increase in volume, with pricing and product mix adding the rest.

The stock responded immediately. PG climbed as much as 6.2% intraday to $166.55 and closed up 5.6% at $165.59, its highest level since February 27. Trading volume hit about 21.9 million shares — roughly 124% above its average daily volume — a sign this was not a quiet drift higher but a genuine rush into the stock.

Why it's blowing up

Timing did a lot of the work. Thursday was a rough day for the market's high flyers: the Nasdaq Composite fell 2.6%, the Philadelphia Semiconductor Index dropped 6.7%, and Meta slid nearly 7% as investors balked at the cost of the AI build-out. Against that backdrop, money rotated into defensive names — staples, utilities and health care — and P&G, the maker of Tide, Pampers, Gillette and Crest, was the day's standout safe haven.

The quality of the beat mattered too. This was not a quarter rescued by price hikes alone. Volume growth did the heavy lifting, US sales improved to a 3% gain after falling 1% in the prior quarter, and China sales accelerated to 8% growth from 4%. Every one of P&G's five segments grew: Fabric & Home Care rose 4% to $8.21 billion, Beauty rose 6% to $4.41 billion, Baby, Feminine & Family Care rose 3% to $5.32 billion, Health Care rose 3% to $3.32 billion, and Grooming rose 4% to $1.89 billion.

Key facts

Core EPS: $2.00 vs. $1.89 consensus estimate (diluted EPS $1.97)
Net sales: $23.28 billion, up 4% year over year, vs. ~$22.8 billion expected
Organic sales: +4%, led by 2.4% volume growth
Stock move: +5.6% to $165.59 — highest level since February; volume 124% above average
Guidance: Full-year fiscal 2027 outlook maintained — organic sales growth of 1% to 3% and EPS of $6.89 to $7.11; all-in sales growth outlook raised to 2% to 4% following the Thorne HealthTech deal
Dividend: Quarterly dividend of $1.0885 per share, payable November 16 to shareholders of record October 23

The catch investors are watching

The quarter was not flawless. Adjusted gross margin fell 150 basis points to 49.8% as cost inflation outpaced the company's savings program, and management expects inflation to remain a meaningful headwind this year. P&G also kept — rather than raised — its organic growth and earnings outlook, which is why some analysts describe the post-earnings price as a little heated even as they praise the execution.

What's next

Attention now turns to whether P&G can sustain volume-led growth through the holiday quarter while absorbing cost pressure, and to how the recently completed tie-up with premium supplement maker Thorne HealthTech (a deal valued at around $4 billion) feeds into its health care business. With the broader market wobbling over AI spending, P&G's next test is simple: keep proving that steady, boring growth is exactly what investors want right now.

This post reports market news only and is not financial advice.

FAQ

Why did Procter & Gamble stock jump on October 22, 2026?

PG beat fiscal Q1 2027 estimates — core EPS of $2.00 vs. $1.89 expected and sales of $23.28 billion vs. ~$22.8 billion expected — and investors rotated into defensive consumer staples stocks during a sharp tech selloff.

How much did P&G stock rise?

Shares closed up 5.6% at $165.59, after trading as much as 6.2% higher intraday, reaching the stock's highest level since February 2026 on volume about 124% above average.

Did P&G raise its guidance?

P&G maintained its fiscal 2027 organic sales growth outlook of 1% to 3% and its EPS range of $6.89 to $7.11, while lifting its all-in sales growth range to 2% to 4% because of the Thorne acquisition.

Which P&G segments grew in the quarter?

All five: Fabric & Home Care (+4%), Beauty (+6%), Baby, Feminine & Family Care (+3%), Health Care (+3%) and Grooming (+4%).